sr-147778 has been researched along with Obesity* in 1 studies
1 review(s) available for sr-147778 and Obesity
Article | Year |
---|---|
Will the new CB1 cannabinoid receptor antagonist SR-147778 have advantages over rimonabant?
Topics: Alcoholism; Animals; Humans; Obesity; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant | 2005 |